Cargando…

Biomarkers to Measure Treatment Effects in Alzheimer's Disease: What Should We Look for?

It is often surprisingly difficult to tell whether a treatment for Alzheimer's disease is effective. Biomarkers might offer the potential of a quantifiable objective measure of treatment effectiveness. This paper suggests several criteria by which biomarkers might be evaluated as outcomes measu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rockwood, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199052/ https://www.ncbi.nlm.nih.gov/pubmed/22028983 http://dx.doi.org/10.4061/2011/598175

Ejemplares similares

Supporting hemodynamics: what should we target? What treatments should we use?
por: Gattinoni, Luciano, et al.
Publicado: (2013)

What we have learned from the past and how we should look forward
por: Wellmer, Friedrich-W.
Publicado: (2022)

Understanding environmental influences on nutrition and physical activity behaviors: where should we look and what should we count?
por: Ball, Kylie, et al.
Publicado: (2006)

Con: Can biomarkers be gold standards in Alzheimer's disease?
por: Rockwood, Kenneth
Publicado: (2010)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

The ideal marker for measuring GFR: what are we looking for?
por: Claudio, Maioli, et al.
Publicado: (2020)

Looking at the day after COVID-19… what laryngeal sequelae should we expect?
por: Torretta, Sara, et al.
Publicado: (2021)

What we see depends on what we look for
por: Tomšič, Anton, et al.
Publicado: (2020)

Treatment of Delirium in Older Persons: What We Should Not Do!
por: Lauretani, Fulvio, et al.
Publicado: (2020)

Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Clinical Remission: What Should We Look For?
por: Stroie, Tudor, et al.
Publicado: (2022)

What should a quantitative model of masking look like and why would we want it?
por: Francis, Gregory
Publicado: (2008)

Should Canadian patients look forward to aducanumab for Alzheimer disease?
por: Watt, Jennifer A., et al.
Publicado: (2021)

Sarcoma Stem Cells: Do We Know What We Are Looking for?
por: Trucco, Matteo, et al.
Publicado: (2012)

What Should a Doctor Look Like?
por: Zhong, Diana
Publicado: (2021)

The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay?
por: Colonetti, Karina, et al.
Publicado: (2018)

Severe asthma and allergy - should we look for the allergens
por: Lazova, Snezhina, et al.
Publicado: (2015)

Tics and Shorter Stature: Should We Be Looking for an Association?
por: Holleb, Peter, et al.
Publicado: (2014)

Thoughts From the Trenches: Should We Look at the “Healthy”?
por: Martínez-Taboada, Víctor M., et al.
Publicado: (2020)

Circadian Rhythms in Legumes: What Do We Know and What Else Should We Explore?
por: Kugan, Hazel Marie, et al.
Publicado: (2021)

Five decades of Fontan palliation: What have we learned? What should we expect?
por: Hassan, Adil, et al.
Publicado: (2023)

What Should We Eat?
Publicado: (1909)

METTL16 in human diseases: What should we do next?
por: Zhang, Hui, et al.
Publicado: (2023)

Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know
por: Petrides, Petro E.
Publicado: (2022)

Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?
por: Rockwood, Neesha, et al.
Publicado: (2019)

What We Might Find If We Only Looked
por: Lanspa, Michael J., et al.
Publicado: (2021)

The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
por: Kurkinen, Markku, et al.
Publicado: (2023)

Drug Allergy in Children: What Should We Know?
por: Park, Ji Soo, et al.
Publicado: (2019)

Endometriosis and the effects of dietary interventions: what are we looking for?
por: Nap, Annemiek, et al.
Publicado: (2022)

The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
por: Russell, Jill, et al.
Publicado: (2020)

Why We Should Take a Closer Look at Gestures
por: Walther, Sebastian, et al.
Publicado: (2016)

What Should We Be Recommending for the Treatment of Enteric Fever?
por: Parry, Christopher M, et al.
Publicado: (2023)

Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?
por: Durazzo, Marilena, et al.
Publicado: (2022)

Fibre Intake in Chronic Kidney Disease: What Fibre Should We Recommend?
por: Cigarrán Guldris, Secundino, et al.
Publicado: (2022)

What Fillings Should We Use
por: Bonwill, W. G. A.
Publicado: (1885)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

Personality neuroscience and psychopathology: should we start with biology and look for neural-level factors?
por: McNaughton, Neil
Publicado: (2020)

The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
por: Chandra, Sidhanth, et al.
Publicado: (2023)

Atrial fibrillation in heart failure: what should we do?
por: Kotecha, Dipak, et al.
Publicado: (2015)

What We Should Consider for Full Densification when Sintering
por: Kang, Suk-Joong L.
Publicado: (2020)

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?
por: Li, Xiaoming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2vjcrkbller55bkueqj23b9288